Latest Commercialisation News

Hazer Group and KBR have secured a paid pre-feasibility study with a leading Japanese power utility to explore large-scale deployment of methane pyrolysis technology, reinforcing Hazer's foothold in Japan's clean hydrogen market.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.

Euro Manganese has signed a non-binding term sheet with US battery materials producer 6K Energy, marking a critical step towards commercialising its Chvaletice manganese project with validated product quality and supportive financing terms.

Galilee Energy has raised A$3.5 million to fund a sidetrack drilling program at Zydeco-1, targeting 13.7 Bcf of gas and 610,000 barrels of condensate in Louisiana, while selling its Glenaras Gas Project to sharpen focus on US growth.

Papyrus Australia has arranged a further $500,000 in unsecured loan facilities from four sophisticated investors, with conversion to unsecured convertible notes subject to shareholder approval at the 2026 AGM.

InVert Graphite has completed the acquisition of RapidGraphite, gaining exclusive rights to the RapidPulse™ technology, and raised A$2.5 million to fund scale-up trials aimed at transforming battery-grade graphite production.

Sierra Nevada Gold (ASX: SNX) is refocusing its exploration budget and management attention on its promising As Safra copper-gold project in Saudi Arabia, triggering a strategic review and commercialisation of its Nevada, USA portfolio which is attracting strong buyer interest.

Challenger Gold has raised A$85 million and revamped its leadership to accelerate development of the Hualilán Gold Project, shifting from toll treatment to an integrated mining and processing operation backed by a new 35,000-metre drilling campaign.

Podium Minerals has secured a $4 million underwritten share purchase plan to fund advancing metallurgical work and site rehabilitation at its Parks Reef PGM Project, following a significant step-change in concentrator performance.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

Pathkey.AI has appointed former Altium chairman Sam Weiss as a strategic advisor and raised $2.8 million in a placement led by Weiss, aiming to accelerate its AI-powered chip design platform Chipforge.

Andromeda Metals launches a $3 million Share Purchase Plan to fund the next phase of its High Purity Alumina project, aiming to complete a Pre-Feasibility Study and advance commercialisation.